In focus
Latest feed
Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts
The High-Stakes Battle: Why Pharmacy Benefit Managers Are Fighting Tooth and Nail
Cipla Shares Poised for a Jump as Citi Flags Near‑Term US Growth Triggers
The Eli Lilly Rollercoaster: Deciphering a Volatile Week in the Market
